Lord, Abbett & Co’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCE
CC
MF
BCM
FCM
Lord, Abbett & Co's ONCE Position: Q1 2019 in Review
Lord, Abbett & Co sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 66,423 shares — an estimated $2.6M sold.
Lord, Abbett & Co first reported a position in ONCE in Q1 2015 and held it in 16 quarters. The position peaked at $98.9M in Q2 2018. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.
- Lord, Abbett & Co reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
- Lord, Abbett & Co sold 66,423 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $2.6M.
- Lord, Abbett & Co first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 16 quarters.
- Lord, Abbett & Co's Spark Therapeutics, Inc. Common Stock position peaked at $98.9M in Q2 2018.
- 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.
Based on Lord, Abbett & Co's 13F filing for Q1 2019, filed 15 May 2019.